
LifeVantage Corp
LFVNNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$7.94
Day High
$8.50
Day Low
$7.20
Prev. Close
$7.67
VolumeShares traded today.
425.00K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$99.29M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
17.63
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$15.00
52W LowLowest price over the past 52 weeks.
$3.90
50D MAAverage closing price over the last 50 trading days.
$5.04
200D MAAverage closing price over the last 200 trading days.
$7.06
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+46.6%1M
+55.8%6M
+16.2%YTD
+30.5%1Y
-39.7%About
Protandim is a herbal dietary supplement marketed with unsupported claims that it can treat a number of medical conditions. The product is a patented mix of five herbal ingredients and sold by LifeVantage Corporation, a Utah-based multi-level marketing company. The manufacturers of Protandim make no claims that it can prevent or cure any medical conditions. In 2017, LifeVantage was issued a warning letter by the U.S. Food and Drug Administration (FDA) regarding illegal advertising claims on the company's websites suggesting that Protandim can help to cure various ailments, including cancer and diabetes.
www.lifevantage.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade LFVN
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.